bioAffinity Technologies Inc. (BIAF) News
Filter BIAF News Items
BIAF News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BIAF News Highlights
- BIAF's 30 day story count now stands at 2.
- Over the past 5 days, the trend for BIAF's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about BIAF are LUNG and CMS.
Latest BIAF News From Around the Web
Below are the latest news stories about BIOAFFINITY TECHNOLOGIES INC that investors may wish to consider to help them evaluate BIAF as an investment opportunity.
bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of DirectorsSAN ANTONIO, December 05, 2023--Jamie Platt, Ph.D., joins the bioAffinity Technologies Board of Directors |
CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024SAN ANTONIO,, November 30, 2023--CMS has made a final determination for payment for CyPath® Lung, a noninvasive test for early-stage lung cancer, for the 2024 calendar year. |
bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology PostSAN ANTONIO, November 28, 2023--bioAffinity Technologies VP of Research David Elzi, Ph.D., named to post with the American Society for Cell Biology |
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer ScreeningSAN ANTONIO, Texas, November 15, 2023--bioAffinity Technologies today launched a campaign in partnership with the ACS to increase lung cancer screening in Texas. |
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateSAN ANTONIO, November 14, 2023--bioAffinity Technologies reports third quarter 2023 financial results and provides business update. |
bioAffinity Technologies Names Dallas J. Coleman as National Director of SalesSAN ANTONIO, November 06, 2023--bioAffinity Technologies announces the appointment of Dallas Coleman as National Director of Sales. |
bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth ConferenceSAN ANTONIO, Texas, October 10, 2023--bioAffinity Technologies presents at Dawson James Small Cap Growth Conference this week |
Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceJUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8th Annual Dawson James Small Cap Growth Conference on October 12, 2023, at the Wyndham Grand Hotel in Jupiter, FL. Dawson James’ flagship Small Cap Growth Conference brings together senior leadership from over 30 of the most innovative companies at the forefront of healthcare, technology and consu |
bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology ServicesSAN ANTONIO, Texas, September 19, 2023--bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, announces the acquisition of the laboratory assets of Village Oaks Pathology Services, P.A., d/b/a Precision Pathology Services, a clinical laboratory accredited by the College of American Pathologists (CAP) and certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988. The laboratory as |
bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment ConferenceSAN ANTONIO, September 07, 2023--bioAffinity President and CEO Maria Zannes will present at H.C. Wainwright Global Investment Conference Sept. 11-13. |